Preparation method of 3,5-dibenzoyl-2-deoxy-2-fluoro-2-methyl-D-ribo-gamma-lactone
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 苏州东南药业股份有限公司
- Publication Date
- 2014-05-21
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of medicine and chemical industry, and specifically relates to a preparation method of 3,5-dibenzoyl-2-deoxy-2-fluoro-2methyl-D-ribose-γ-lactone (sofosbuvir) . Background technique
[0002] Hepatitis C virus (HCV) infection is a major health problem leading to chronic liver diseases such as cirrhosis and hepatocellular carcinoma, with an estimated 2-15% of individuals worldwide infected with this virus. According to data, there are about 40 million HCV-infected people in China, accounting for 3.2% of my country's population, and there is an increasing trend. According to the World Health Organization, more than 200 million people are infected with HCV worldwide, and the number increases by about 4 million each year. HCV infection is mainly transmitted through blood sources, such as blood and blood product contamination, syringe contamination, unclean sex and mother-to-child transmission. Once infected with HCV, onl...